NO974579D0 - Derivater av 5H,10H-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-on, deres fremstilling samt medikamenter inneholdende derivatene - Google Patents

Derivater av 5H,10H-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-on, deres fremstilling samt medikamenter inneholdende derivatene

Info

Publication number
NO974579D0
NO974579D0 NO974579A NO974579A NO974579D0 NO 974579 D0 NO974579 D0 NO 974579D0 NO 974579 A NO974579 A NO 974579A NO 974579 A NO974579 A NO 974579A NO 974579 D0 NO974579 D0 NO 974579D0
Authority
NO
Norway
Prior art keywords
derivatives
indeno
pyrazin
imidazo
preparation
Prior art date
Application number
NO974579A
Other languages
English (en)
Other versions
NO309480B1 (no
NO974579L (no
Inventor
Jean-Claude Aloup
Francois Audiau
Michel Barreau
Dominique Damour
Arielle Genevois-Borella
Jean-Claude Hardy
Patrick Jimonet
Franco Manfre
Serge Mignani
Patrick Nemecek
Yves Ribeill
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO974579D0 publication Critical patent/NO974579D0/no
Publication of NO974579L publication Critical patent/NO974579L/no
Publication of NO309480B1 publication Critical patent/NO309480B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO974579A 1995-04-05 1997-10-03 Derivater av 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-on, mellomprodukter samt medikamenter inneholdende derivatene NO309480B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9504013A FR2732681B1 (fr) 1995-04-05 1995-04-05 Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant
PCT/FR1996/000496 WO1996031511A1 (fr) 1995-04-05 1996-04-02 DERIVES DE 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT

Publications (3)

Publication Number Publication Date
NO974579D0 true NO974579D0 (no) 1997-10-03
NO974579L NO974579L (no) 1997-11-26
NO309480B1 NO309480B1 (no) 2001-02-05

Family

ID=9477764

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974579A NO309480B1 (no) 1995-04-05 1997-10-03 Derivater av 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-on, mellomprodukter samt medikamenter inneholdende derivatene

Country Status (27)

Country Link
US (2) US5902803A (no)
EP (1) EP0820455B1 (no)
JP (1) JP4014221B2 (no)
KR (1) KR19980703550A (no)
CN (1) CN1063180C (no)
AR (1) AR002983A1 (no)
AT (1) ATE207923T1 (no)
AU (1) AU705471B2 (no)
BG (1) BG62970B1 (no)
CA (1) CA2215469A1 (no)
CZ (1) CZ285797B6 (no)
DE (1) DE69616532T2 (no)
DK (1) DK0820455T3 (no)
EA (1) EA000218B1 (no)
ES (1) ES2166441T3 (no)
FR (1) FR2732681B1 (no)
HU (1) HUP9801716A3 (no)
IL (1) IL117759A (no)
MX (1) MX9707528A (no)
NO (1) NO309480B1 (no)
NZ (1) NZ305899A (no)
PL (1) PL322621A1 (no)
PT (1) PT820455E (no)
SK (1) SK281274B6 (no)
TW (1) TW492969B (no)
WO (1) WO1996031511A1 (no)
ZA (1) ZA962771B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2743366B1 (fr) * 1996-01-10 1998-02-06 Rhone Poulenc Rorer Sa Derives de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one, leur preparation, leurs intermediaires et les medicaments les contenant
CA2686816A1 (en) * 2007-01-16 2008-07-24 The Johns Hopkins University Use of various glutamate receptor antagonists for delaying or preventing platelet activity or for treating or preventing a thrombotic disease or disorder
MA49014A (fr) 2017-03-21 2020-02-05 Arbutus Biopharma Corp Dihydroindène-4-carboxamides substitués, leurs analogues et procédés d'utilisation correspondant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696466B1 (fr) * 1992-10-02 1994-11-25 Rhone Poulenc Rorer Sa Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.

Also Published As

Publication number Publication date
IL117759A0 (en) 1996-08-04
JPH11503144A (ja) 1999-03-23
US5902803A (en) 1999-05-11
EA199700296A1 (ru) 1998-04-30
EA000218B1 (ru) 1998-12-24
US6057454A (en) 2000-05-02
JP4014221B2 (ja) 2007-11-28
IL117759A (en) 1999-06-20
HUP9801716A3 (en) 1999-05-28
SK133797A3 (en) 1998-03-04
CN1063180C (zh) 2001-03-14
KR19980703550A (ko) 1998-11-05
CA2215469A1 (fr) 1996-10-10
ATE207923T1 (de) 2001-11-15
NO309480B1 (no) 2001-02-05
DK0820455T3 (da) 2002-02-18
EP0820455A1 (fr) 1998-01-28
HUP9801716A1 (hu) 1998-11-30
ES2166441T3 (es) 2002-04-16
BG101941A (en) 1998-11-30
AU5402996A (en) 1996-10-23
FR2732681A1 (fr) 1996-10-11
MX9707528A (es) 1997-11-29
CZ285797B6 (cs) 1999-11-17
DE69616532D1 (de) 2001-12-06
CZ314097A3 (cs) 1998-01-14
ZA962771B (en) 1996-10-11
EP0820455B1 (fr) 2001-10-31
DE69616532T2 (de) 2002-05-23
FR2732681B1 (fr) 1997-07-04
SK281274B6 (sk) 2001-02-12
PL322621A1 (en) 1998-02-02
PT820455E (pt) 2002-04-29
NZ305899A (en) 1998-06-26
CN1180357A (zh) 1998-04-29
NO974579L (no) 1997-11-26
WO1996031511A1 (fr) 1996-10-10
BG62970B1 (bg) 2000-12-29
AR002983A1 (es) 1998-05-27
TW492969B (en) 2002-07-01
AU705471B2 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
NO307091B1 (no) Nye pyrido[3,2-e]pyrazinoner, legemiddel inneholdende samme, samt anvendelse av samme for fremstilling av legemiddel
NO984852L (no) Nye benzazepinderivater, medikamenter inneholdende forbindelsene samt deres anvendelse ved fremstilling av medikamentene
NO895012L (no) Fremgangsmaate for fremstilling av varige titandioxydpigmenter.
AU3573793A (en) 3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidine-4-ones pharmaceutical compositions containing the same and the preparation thereof
NO890969L (no) Fremgangsmaate for fremstilling av isoindolinderivater.
NZ219386A (en) Naphtho(1,2-b)-1,4-thiazepinone derivatives and pharmaceutical compositions
NO308469B1 (no) Triazin-inneholdende anioniske forbindelser egnet som antivirale forbindelser, anvendelse av forbindelsene samt farmasøytisk blanding
AU1382797A (en) 5h,10h-imidazo{1,2-a}indolo{3,2-e}pyrazine-4-one derivatives, preparation thereof and drugs containing same
NO305948B1 (no) Basisk substituerte benzolguanidiner, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO960699L (no) Antimigren 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner
NO924990D0 (no) Substituerte pyridin-n-oksyder, fremgangsmaater for fremstilling av dem, samt anvendelser av dem
AU1383097A (en) 5h,10h-imidazo{1,2-a}indeno{1,2-e}pyrazine-4-one derivatives, preparation thereof, intermediates thereof and drugs containing same
NO943898D0 (no) 3,4-dihydro-2H-1,2,4-benzotiadiazin-1,1-dioksyd-3-karboksylsyrederivater, deres fremstilling samt medikamentene inneholdende derivatene
NO308251B1 (no) Karbohydratderivater, farmasøytisk blanding inneholdende karbohydratderivater samt anvendelse av samme
FI895069A0 (fi) Funktionsanordning av modulkonstruktion foer valsarna i en maskinkalander.
NO974579D0 (no) Derivater av 5H,10H-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-on, deres fremstilling samt medikamenter inneholdende derivatene
NO891985L (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
NO306212B1 (no) Oligosakkarid selektivt for 1,3-L-fucosyltransferase samt anvendelse av samme
AU1382997A (en) 5h,10h-imidazo{1,2-a}indeno{1,2-e}pyrazine-4-one derivatives, preparation thereof and drugs containing same
NO951101L (no) 5H,10H-imidazol(1,2-a)indeno(1,2-e)pyrazin-4-on-derivater, deres fremstilling og medikamenter inneholdende forbindelsene
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
AU1382897A (en) 2-substituted 5h,10h-imidazo{1,2-a}indeno{1,2-e}pyrazine-4-ones, preparation thereof and drugs containing same
AU6992096A (en) Indeno{1,2-e}pyrazin-4-ones, preparation thereof and medicaments containing same
FI933872A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat
NO920168D0 (no) Absorpsjonsmiddel, fremgangsmaate for fremstilling av absorpsjonsmiddel samt anvendelse av dette

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2003